Reply: Lecanemab: turning point, or status quo? An ethics perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply: Lecanemab: turning point, or status quo? An ethics perspective

Published:2023-03-30 Issue:9 Volume:146 Page:e73-e73
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Hardy John¹²³,Mummery Catherine²

Affiliation:

1. Reta Lilla Weston Research Laboratories, UCL Institute of Neurology , London WC1N 3BG , UK

2. Department of Neurodegenerative Disease, UCL Institute of Neurology , London WC1N 3BG , UK

3. Dementia Research Institute, UCL Institute of Neurology , London WC1N 3BG , UK

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad102/50710085/awad102.pdf

Reference5 articles.

1. A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease;Karran;Ann Neurol,2014

2. The amyloid hypothesis in Alzheimer disease: New insights from new therapeutics;Karran;Nat Rev Drug Discov,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Decade of Protecting Progress: Ethics Review;Journal of Alzheimer's Disease;2024-08-20

2. Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis;International Journal of Molecular Sciences;2023-09-24

3. Philosophers of Medicine Should Write More Letters for Medical Journals;Philosophy of Medicine;2023-05-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP